Does Morbid Obesity (BMI ≥40 kg/m2) Impact Operative Time, Blood Loss, Length of Stay, or Complications Following Anatomic Total Shoulder Arthroplasty? | ||
| The Archives of Bone and Joint Surgery | ||
| مقاله 3، دوره 11، شماره 6، شهریور 2023، صفحه 389-397 اصل مقاله (813.31 K) | ||
| نوع مقاله: RESEARCH PAPER | ||
| شناسه دیجیتال (DOI): 10.22038/abjs.2023.70400.3306 | ||
| نویسندگان | ||
| Konrad I. Gruson* 1؛ Yungtai Lo2؛ Evan Rothchild2؛ Priyam Shah2؛ Eloy Tabeayo1؛ Feras Qawasmi1 | ||
| 11Montefiore Medical Center - Department of Orthopedic Surgery, Bronx, New York, USA | ||
| 22Albert Einstein College of Medicine - Department of Epidemiology & Population Health, Bronx, New York, USA | ||
| چکیده | ||
| Objectives: There have been conflicting reports regarding the effects of obesity on both surgical time and blood loss following anatomic shoulder arthroplasty. Varying categories of obesity has made comparison amongst existing studies difficult. Methods: A retrospective review of consecutive anatomic shoulder arthroplasty cases (aTSA) was undertaken. Demographic data, including age, gender, body mass index (BMI), age-adjusted Charleson Comorbidity Index (ACCI), operative time, hospital length of stay (LOS), and both POD#1 and discharge visual analogue score (VAS) was collected. Intra-operative total blood volume loss (ITBVL) and need for transfusion was calculated. BMI was categorized as non-obese (<30 kg/m2), obese (30-40 kg/m2) and morbidly obese (≥40 kg/m2). Unadjusted associations of BMI with operative time, ITBVL and LOS were examined using Spearman correlation coefficients. Regression analysis was used to identify factors associated with hospital LOS. Results: There were 130 aTSA cases performed, including 45 short stem and 85 stemless implants, of which 23 (17.7%) were morbidly obese, 60 (46.2%) were obese and 47 (36.1%) were non-obese. Median operative time for the morbidly obese cohort was 119.5 minutes (IQR 93.0, 142.0) versus 116.5 minutes (IQR 99.5, 134.5) for the obese cohort versus 125.0 minutes (IQR, 99.0, 146.0) for the non-obese cohort. (P=0.61) The median ITBVL for the morbidly obese cohort was 235.8 ml (IQR 144.3, 329.7) versus 220.1 ml (IQR 147.7, 262.7) for the obese cohort versus 216.3 ml (IQR 139.7, 315.5) for the non-obese cohort. (P=0.72). BMI ≥40kg/m2 (IRR 1.32, P=0.038), age (IRR 1.01, P=0.026), and female gender (IRR 1.54, P<0.001) were predictive of increased LOS. There was no difference with regards to in-hospital medical complications (P=0.13), surgical complications (P=1.0), need for re-operation (P=0.66) and 30-day return to the ER (P=0.06). Conclusion: Morbid obesity was not associated with increased surgical time, ITBVL and perioperative medical or surgical complications following aTSA, though it was predictive of increased hospital LOS. Level of evidence: III | ||
| کلیدواژهها | ||
| Anatomic total shoulder؛ Blood loss؛ Complications؛ Length of stay؛ Morbid obesity؛ Obesity؛ Operative time | ||
| مراجع | ||
|
1. Wagner ER, Farley KX, Higgins I, Wilson JM, Daly CA, Gottschalk MB. The incidence of shoulder arthroplasty: rise and future projections compared with hip and knee arthroplasty. J Shoulder Elbow Surg. 2020; 29(12):2601- 2609. doi: 10.1016/j.jse.2020.03.049. 2. Dillon MT, Chan PH, Inacio MCS, Singh A, Yian EH, Navarro RA. Yearly trends in elective shoulder arthroplasty, 2005- 2013. Arthritis Care Res (Hoboken). 2017; 69(10):1574- 1581. doi: 10.1002/acr.23167. 3. Wang YC, McPherson K, Marsh T, Gortmaker SL, Brown M. Health and economic burden of the projected obesity trends in the USA and the UK. Lancet .2011;378(9793):815- 825. doi: 10.1016/S0140-6736(11)60814-3. 4. Wang KY, Quan T, Best MJ, Gu A, McFarland EG, Srikumaran U. BMI and male gender are associated with increased operative time during total shoulder arthroplasty: an analysis of 16,568 patients. Seminars in Arthroplasty: JSES. 2021; 31(1):346-352. doi: 10.1053/j.sart.2021.02.007. 5. Chalmers PN, Gupta AK, Rahman Z, Bruce B, Romeo AA, Nicholson GP. Predictors of early complications of total shoulder arthroplasty. J Arthroplasty. 2014; 29(4):856-860. doi: 10.1016/j.arth.2013.07.002. 6. Li X, Williams PN, Nguyen JT, Craig EV, Warren RF, Gulotta LV. Functional outcomes after total shoulder arthroplasty in obese patients. J Bone Joint Surg Am. 2013; 95(21):e160. doi: 10.2106/JBJS.L.01145. 7. Mahmoud S, Dong Y, Loloi J, Gruson KI. Are perioperative complications and clinical outcomes following reverse shoulder arthroplasty adversely affected by obesity? A systematic review. Seminars in Arthroplasty: JSES. 2021; 31(1):147-158. doi:10.1053/j.sart.2020.11.006. 8. Kashanchi KI, Nazemi AK, Komatsu DE, Wang ED. Impact of operative time on short-term adverse events following total shoulder arthroplasty. Seminars in Arthroplasty: JSES. 2020:30(3):227-236. doi: 10.1053/j.sart.2020.07.007. 9. Wilson JM, Holzgrefe RE, Staley CA, Karas S, Gottschalk MB, Wagner ER. The effect of operative time on early postoperative complications in total shoulder arthroplasty: An analysis of the ACS-NSQIP database. Shoulder Elbow. 2021; 13(1):79-88. doi: 10.1177/1758573219876573. 10. Malcherczyk D, Abdelmoula A, Heyse TJ, Peterlein CD, Greene B, El-Zayat BF. Bleeding in primary shoulder arthroplasty. Arch Orthop Trauma Surg. 2018; 138(3):317-323. doi: 10.1007/s00402-017-2851-3. 11. Pappou I, Virani NA, Clark R, Cottrell BJ, Frankle MA. Outcomes and costs of reverse shoulder arthroplasty in the morbidly obese: a case control study. J Bone Joint Surg Am. 2014; 96:1169-1176. doi: 10.2106/JBJS.M.00735. 12. Wiater JM, Carpenter S, Koueiter DM, Marcantonio D, Wiater BP. Influence of body mass index on clinical outcomes in reverse total shoulder arthroplasty. J Surg Orthop Adv. 2017; 26(3):134–142. doi: 10.3113/JSOA.2017.0134. 13. Dong Y, Loloi J, Mahmoud S, Charubhumi V, Tabeayo E, Gruson KI. The association of elevated body mass index (BMI) with complications and outcomes following anatomic total shoulder arthroplasty: a systematic review. Seminars in Arthroplasty: JSES. 2022; 32(1):184-194. doi: 10.1053/j.sart.2021.05.021. 14. Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994; 47(11):1245-1251. 15. Anastasio AT, Okafor C, Garrigues GE, Klifto CS, Lassiter T, Anakwenze O. Stemmed versus stemless total shoulder arthroplasty: a comparison of operative times. Seminars in Arthroplasty: JSES. 2021; 31(4):831-835. doi: 10.1053/j.sart.2021.05.013. 16. Nadler SB, Hidalgo JH, Bloch T. Prediction of blood volume in normal human adults. Surgery. 1962; 51(2):224-232. PMID: 21936146. 17. Sehat KR, Evans RL, Newman JH. Hidden blood loss following hip and knee arthroplasty. Correct management of blood loss should take hidden loss into account. J Bone Joint Surg Br. 2004; 86(4):561-565. 18. Millar NL, Deakin AH, Millar LL, Kinnimonth AW, Picard F. Blood loss following total knee replacement in the morbidly obese: Effects of computer navigation. Knee. 2011; 18(2):108-112. doi: 10.1016/j.knee.2010.03.002. 19. Gross JB. Estimating allowable blood loss: corrected for dilution. Anesthesiology. 1983; 58(3):277-80. doi: 10.1097/00000542-198303000-00016. 20. Wiater JM, Levy JC, Wright SA, et al. Prospective, blinded, randomized controlled trial of stemless versus stemmed humeral components in anatomic total shoulder arthroplasty: results at short-term follow-up. J Bone Joint Surg Am. 2020; 102(22):1974-1984. doi: 10.2106/JBJS.19.01478. 21. Menendez ME, Baker DK, Fryberger CT, Ponce BA. Predictors of extended length of stay after elective shoulder arthroplasty. J Shoulder Elbow Surg. 2015; 24:1527-1533. doi: 10.1016/j.jse.2015.02.014. 22. Griffin JW, Novicoff WM, Browne JA, Brockmeier SF. Morbid obesity in total shoulder arthroplasty: risk, outcomes, and cost analysis. J Shoulder Elbow Surg. 2014; 23(10):1444-8. doi: 10.1016/j.jse.2013.12.027. 23. Bixby EC, Boddapati V, Anderson MJJ, Mueller JD, Jobin CM, Levine WN. Trends in total shoulder arthroplasty from 2005 to 2018: lower complications rates and shorter lengths of stay despite patients with more comorbidities. JSES Int. 2020; 4(3):657-661. doi: 10.1016/j.jseint.2020.04.024. 24. King JJ, Patrick MR, Struk AM, et al. Perioperative factors affecting the length of hospitalization after shoulder arthroplasty. J Am Acad Orthop Surg Glob Res Rev. 2017; 1(6):e026. doi: 10.5435/JAAOSGlobal-D-17-00026. 25. Dunn JC, Lanzi J, Kusnezov N, Bader J, Waterman BR, Belmont PJ Jr. Predictors of length of stay after elective total shoulder arthroplasty in the United States. J Shoulder Elbow Surg. 2015; 24(5):754-759. doi: 10.1016/j.jse.2014.11.042. 26. Hung NJ, Wong SE. Gender influences on shoulder arthroplasty. Curr Rev Musculoskelet Med. 2022; 15(1):21- 26. doi: 10.1007/s12178-021-09737-0. 27. Sethi PM, Mandava NK, Liddy N, Denard PJ, Haidamous G, Reimers CD. Narcotic requirements after shoulder arthroplasty are low using a multimodal approach to pain. JSES Int. 2021; 5(4):722-728. doi: 10.1016/j.jseint.2021.02.005. 28. Werner BC, Burrus MT, Browne JA, Brockmeier SF. Superobesity (body mass index >50 kg/m2) and complications after total shoulder arthroplasty: an incremental effect of increasing body mass index. J Shoulder Elbow Surg. 2015; 24(12):1868-1875. doi:10.1016/j.jse.2015.05.046. 29. Singh A, Yian EH, Dillon MT, Takayanagi M, Burke MF, Navarro RA. The effect of surgeon and hospital volume on shoulder arthroplasty perioperative quality metrics. J Shoulder Elbow Surg. 2014; 23(8):1187-1194. doi: 10.1016/j.jse.2013.11.017. | ||
|
آمار تعداد مشاهده مقاله: 415 تعداد دریافت فایل اصل مقاله: 387 |
||